NCT05812781View on ClinicalTrials.gov

A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome

PHASE2CompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

March 18, 2023

Primary Completion Date

March 6, 2024

Study Completion Date

March 6, 2024

Conditions

Cryopyrin Associated Periodic Syndrome

Interventions

DRUG

VTX2735

Dose A

DRUG

VTX2735

Dose B

Trial Locations (2)

31904

Local Site # 223, Columbus

92123

Local Site # 222, San Diego

All Listed Sponsors

lead

Zomagen Biosciences Ltd.

INDUSTRY